Peter Thiel

Angel

Portfolio

companies

Portfolio companies

Lindus Health

Lindus Health operates a technology platform to run faster end-to-end clinical trials.

Recent investments

Series A16 August 2023

£14.1M

Lindus Health secures £14.1m Series A funding led by Creandum to scale clinical trials

BioTech

Creandum led the Series A round with participation from Peter Thiel, firstminute, Seedcamp, Hambro Perks and Amino Collective.

"Clinical trials are the biggest bottleneck to improving human health. We deliver clinical trials three times faster than the industry standard, working with biotech pioneers to get new treatments to patients more quickly."

— Michael Young, Co-Founder

Lindus Health—London, UK

Creandum + 5 others

1 June 2023

$6.0M

Lindus Health raises $6m from backers including Peter Thiel, Firstminute, and Seedcamp to accelerate clinical trials.

BioTech

The London-based clinical trials platform has secured $6m to date from high-profile investors.

"Clinical trials are the biggest bottleneck to improving human health. We’re working with high-growth companies developing the next wave of breakthrough treatments to accelerate the clinical trials process."

— Michael Young, Co-Founder

Lindus Health—London, UK

Firstminute Capital + 2 others